Investing.com -- BioAge Labs, Inc. (NASDAQ:BIOA) stock surged 21% Monday after the clinical-stage biopharmaceutical company announced additional positive interim data from its Phase 1 trial of BGE-102 ...
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities ...
January Nat Gas seasonal softness is showing up right on cue, thanks to those stuffed late-fall storage levels acting as a ...
The American College of Cardiology issued its inaugural JACC Cardiovascular Statistics report, highlighting the prevalence of ...
ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...
Acquisition to expand urology offerings for people living with overactive bladder MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: ...
Through its commitment to a data-driven approach to improving cardiovascular health, the Journal of the American College of ...
The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...
JACC’s new cardiovascular report shows rising risk factors, worsening outcomes, and care gaps in recent years in the US. The ...
Morning Overview on MSN
99% of heart attacks and strokes trace back to 4 risks, study says
Cardiovascular diseases are still the world’s top killer, yet new research suggests they are far less random than they can ...
Discover economic factors leading to currency depreciation, including trade dynamics, interest rates, and political stability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback